102 related articles for article (PubMed ID: 14610232)
1. Gastrointestinal absorption of recombinant hirudin-2 in rats.
Yan X; Wang X; Zhang X; Zhang Q
J Pharmacol Exp Ther; 2004 Feb; 308(2):774-9. PubMed ID: 14610232
[TBL] [Abstract][Full Text] [Related]
2. [Absorption of recombinant hirudin in rats GI tract].
Yan XY; Zhang XN; Zhang Q
Yao Xue Xue Bao; 2004 Jan; 39(1):77-80. PubMed ID: 15127588
[TBL] [Abstract][Full Text] [Related]
3. [Degradation of recombinant hirudin-2 in nasal mucosa of rabbits in vitro].
Zhang YJ; Wu JM; Zhang Q; Chen MX; Sun WJ
Yao Xue Xue Bao; 2006 Nov; 41(11):1099-103. PubMed ID: 17262955
[TBL] [Abstract][Full Text] [Related]
4. Investigation on recombinant hirudin via oral route.
Cen X; Ni J; Tan T; Liu X; Li C; Chen J; Huang Y; Zhu S; Bi Q
Peptides; 2006 Apr; 27(4):836-40. PubMed ID: 16469415
[TBL] [Abstract][Full Text] [Related]
5. Nasal recombinant hirudin-2 delivery: absorption and its mechanism in vivo and in vitro studies.
Zhang Y; Zhang Q; Sun Y; Sun J; Wang X; Chen M
Biol Pharm Bull; 2005 Dec; 28(12):2263-7. PubMed ID: 16327162
[TBL] [Abstract][Full Text] [Related]
6. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
[TBL] [Abstract][Full Text] [Related]
7. [The pharmacokinetics and pharmacodynamics of recombinant hirudin-2 nasal spray].
Zhang YJ; Zhang Q; Hou JL; Wang XL; Chen MX
Yao Xue Xue Bao; 2006 Mar; 41(3):268-71. PubMed ID: 16759001
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes.
Liu Y; Lu WL; Zhang X; Wang XQ; Zhang H; Zhang Q
Peptides; 2005 Mar; 26(3):423-30. PubMed ID: 15652649
[TBL] [Abstract][Full Text] [Related]
9. Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes.
Meng M; Liu Y; Wang YB; Wang JC; Zhang H; Wang XQ; Zhang X; Lu WL; Zhang Q
J Control Release; 2008 Jun; 128(2):113-9. PubMed ID: 18423766
[TBL] [Abstract][Full Text] [Related]
10. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization.
Liu Y; Lu WL; Wang JC; Zhang X; Zhang H; Wang XQ; Zhou TY; Zhang Q
J Control Release; 2007 Feb; 117(3):387-95. PubMed ID: 17207884
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
Freund M; Cazenave JP; Courtney M; Degryse E; Roitsch C; Bernat A; Delebassée D; Defreyn G; Maffrand JP
Thromb Haemost; 1990 Apr; 63(2):187-92. PubMed ID: 2363120
[TBL] [Abstract][Full Text] [Related]
12. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
[TBL] [Abstract][Full Text] [Related]
13. [Promoting mechanism of enhancers and transport pathway of large hydrophilic molecular across nasal epithelium studied by ESR and CLSM technologies].
Zhang YJ; Zhang Q; Yang J; Sun MJ; Wang XL; Chen MX; Wang Q; Jiang H
Yao Xue Xue Bao; 2007 Nov; 42(11):1195-200. PubMed ID: 18300478
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal absorption of recombinant human insulin-like growth factor-I in rats.
Kimura T; Murakawa Y; Ohno M; Ohtani S; Higaki K
J Pharmacol Exp Ther; 1997 Nov; 283(2):611-8. PubMed ID: 9353376
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of freeze-dried powder of recombinate hirudin-2 nanoparticle for nasal delivery and permeability through nasal membrane in vitro].
Chen MX; Zhang JB; Yu JP; Ye J; Wei BH; Zhang YJ
Zhong Yao Cai; 2013 Jun; 36(6):999-1002. PubMed ID: 24380289
[TBL] [Abstract][Full Text] [Related]
16. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.
Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K
Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638
[TBL] [Abstract][Full Text] [Related]
17. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
[TBL] [Abstract][Full Text] [Related]
18. Nanoscaled polyion complex micelles for targeted delivery of recombinant hirudin to platelets based on cationic copolymer.
Wang F; Li X; Zhou Y; Zhang Y; Chen X; Yang J; Huang Y; Liu Y
Mol Pharm; 2010 Jun; 7(3):718-26. PubMed ID: 20349976
[TBL] [Abstract][Full Text] [Related]
19. [Studies on preparation of recombinant hirudin-2 liposome and its pharmacokinetics by nasal delivery in rats].
Zhang YJ; Wang XL; Wu JM; Cheng MX
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):801-4. PubMed ID: 17639978
[TBL] [Abstract][Full Text] [Related]
20. Intestinal absorption of digoxin and interaction with nimodipine in rats.
Kilic FS; Batu O; Sirmagul B; Yildirim E; Erol K
Pol J Pharmacol; 2004; 56(1):137-41. PubMed ID: 15047988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
